Expression of the neural cell adhesion molecule in astrocytic tumors: An inverse correlation with malignancy

Hikaru Sasaki, Kazunari Yoshida, Eiji Ikeda, Hiroaki Asou, Makoto Inaba, Mitsuhiro Otani, Takeshi Kawase

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

BACKGROUND. Cell adhesion molecules are among the key factors in the development of the malignant potential of brain tumors. The aim of this study was to investigate the expression of the neural cell adhesion molecule (NCAM) in human astrocytic tumors and assess any relationship between NCAM expression and the degree of malignancy. METHODS. The expression of NCAM was examined in 52 astrocytic tumors by Western blot analysis. From them the authors selected 23 adult supratentorial ordinary astrocytic tumors and performed quantitative Western blot analysis for each isoform (NCAM 172-180, NCAM 145, NCAM 125-130) to investigate any correlation between the expression of each NCAM isoform and the histologic and biologic malignancy (histology, proliferating cell indices [PCIs] determined by MIBI immunohistochemistry, and manifestation on magnetic resonance images [MRIs]). Immunohistochemistry with antihuman NCAM monoclonal antibody was also performed on the tumors from which cryostat sections were available. RESULTS. Most of the astrocytomas and anaplastic astrocytomas revealed 3 bands at 180, 145, and 125-130kD, whereas in glioblastomas the bands tended to diminish. The expression of each NCAM isoform in astrocytic tumors decreased in proportion to the progression of the histologic malignancy, and the results were also corroborated by immunohistochemical evaluation. An inverse correlation was also observed between the amount of NCAM expression and MIB-1 PCIs. NCAM expression was hardly detectable in those tumors with highly invasive manifestation on MRIs. CONCLUSIONS. To the authors' knowledge, this study provides the first direct evidence that NCAM is down-regulated in the development of the malignancy of astrocytic tumors; and it is suggested that reduced NCAM expression might be involved in the development of biologic malignancy.

Original languageEnglish
Pages (from-to)1921-1931
Number of pages11
JournalCancer
Volume82
Issue number10
DOIs
Publication statusPublished - 1998 May 15

Fingerprint

Neural Cell Adhesion Molecules
Neoplasms
Protein Isoforms
Astrocytoma
Magnetic Resonance Spectroscopy
Western Blotting
Immunohistochemistry
Cell Adhesion Molecules
Glioblastoma
Brain Neoplasms

Keywords

  • Astrocytic tumor
  • Brain tumor
  • Glioma
  • Invasion
  • Inverse correlation
  • Malignancy
  • MIB- 1
  • Neural cell adhesion molecule
  • Proliferation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Expression of the neural cell adhesion molecule in astrocytic tumors : An inverse correlation with malignancy. / Sasaki, Hikaru; Yoshida, Kazunari; Ikeda, Eiji; Asou, Hiroaki; Inaba, Makoto; Otani, Mitsuhiro; Kawase, Takeshi.

In: Cancer, Vol. 82, No. 10, 15.05.1998, p. 1921-1931.

Research output: Contribution to journalArticle

Sasaki, Hikaru ; Yoshida, Kazunari ; Ikeda, Eiji ; Asou, Hiroaki ; Inaba, Makoto ; Otani, Mitsuhiro ; Kawase, Takeshi. / Expression of the neural cell adhesion molecule in astrocytic tumors : An inverse correlation with malignancy. In: Cancer. 1998 ; Vol. 82, No. 10. pp. 1921-1931.
@article{48a24778aed146b4b982d7a93b615f48,
title = "Expression of the neural cell adhesion molecule in astrocytic tumors: An inverse correlation with malignancy",
abstract = "BACKGROUND. Cell adhesion molecules are among the key factors in the development of the malignant potential of brain tumors. The aim of this study was to investigate the expression of the neural cell adhesion molecule (NCAM) in human astrocytic tumors and assess any relationship between NCAM expression and the degree of malignancy. METHODS. The expression of NCAM was examined in 52 astrocytic tumors by Western blot analysis. From them the authors selected 23 adult supratentorial ordinary astrocytic tumors and performed quantitative Western blot analysis for each isoform (NCAM 172-180, NCAM 145, NCAM 125-130) to investigate any correlation between the expression of each NCAM isoform and the histologic and biologic malignancy (histology, proliferating cell indices [PCIs] determined by MIBI immunohistochemistry, and manifestation on magnetic resonance images [MRIs]). Immunohistochemistry with antihuman NCAM monoclonal antibody was also performed on the tumors from which cryostat sections were available. RESULTS. Most of the astrocytomas and anaplastic astrocytomas revealed 3 bands at 180, 145, and 125-130kD, whereas in glioblastomas the bands tended to diminish. The expression of each NCAM isoform in astrocytic tumors decreased in proportion to the progression of the histologic malignancy, and the results were also corroborated by immunohistochemical evaluation. An inverse correlation was also observed between the amount of NCAM expression and MIB-1 PCIs. NCAM expression was hardly detectable in those tumors with highly invasive manifestation on MRIs. CONCLUSIONS. To the authors' knowledge, this study provides the first direct evidence that NCAM is down-regulated in the development of the malignancy of astrocytic tumors; and it is suggested that reduced NCAM expression might be involved in the development of biologic malignancy.",
keywords = "Astrocytic tumor, Brain tumor, Glioma, Invasion, Inverse correlation, Malignancy, MIB- 1, Neural cell adhesion molecule, Proliferation",
author = "Hikaru Sasaki and Kazunari Yoshida and Eiji Ikeda and Hiroaki Asou and Makoto Inaba and Mitsuhiro Otani and Takeshi Kawase",
year = "1998",
month = "5",
day = "15",
doi = "10.1002/(SICI)1097-0142(19980515)82:10<1921::AID-CNCR16>3.0.CO;2-V",
language = "English",
volume = "82",
pages = "1921--1931",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Expression of the neural cell adhesion molecule in astrocytic tumors

T2 - An inverse correlation with malignancy

AU - Sasaki, Hikaru

AU - Yoshida, Kazunari

AU - Ikeda, Eiji

AU - Asou, Hiroaki

AU - Inaba, Makoto

AU - Otani, Mitsuhiro

AU - Kawase, Takeshi

PY - 1998/5/15

Y1 - 1998/5/15

N2 - BACKGROUND. Cell adhesion molecules are among the key factors in the development of the malignant potential of brain tumors. The aim of this study was to investigate the expression of the neural cell adhesion molecule (NCAM) in human astrocytic tumors and assess any relationship between NCAM expression and the degree of malignancy. METHODS. The expression of NCAM was examined in 52 astrocytic tumors by Western blot analysis. From them the authors selected 23 adult supratentorial ordinary astrocytic tumors and performed quantitative Western blot analysis for each isoform (NCAM 172-180, NCAM 145, NCAM 125-130) to investigate any correlation between the expression of each NCAM isoform and the histologic and biologic malignancy (histology, proliferating cell indices [PCIs] determined by MIBI immunohistochemistry, and manifestation on magnetic resonance images [MRIs]). Immunohistochemistry with antihuman NCAM monoclonal antibody was also performed on the tumors from which cryostat sections were available. RESULTS. Most of the astrocytomas and anaplastic astrocytomas revealed 3 bands at 180, 145, and 125-130kD, whereas in glioblastomas the bands tended to diminish. The expression of each NCAM isoform in astrocytic tumors decreased in proportion to the progression of the histologic malignancy, and the results were also corroborated by immunohistochemical evaluation. An inverse correlation was also observed between the amount of NCAM expression and MIB-1 PCIs. NCAM expression was hardly detectable in those tumors with highly invasive manifestation on MRIs. CONCLUSIONS. To the authors' knowledge, this study provides the first direct evidence that NCAM is down-regulated in the development of the malignancy of astrocytic tumors; and it is suggested that reduced NCAM expression might be involved in the development of biologic malignancy.

AB - BACKGROUND. Cell adhesion molecules are among the key factors in the development of the malignant potential of brain tumors. The aim of this study was to investigate the expression of the neural cell adhesion molecule (NCAM) in human astrocytic tumors and assess any relationship between NCAM expression and the degree of malignancy. METHODS. The expression of NCAM was examined in 52 astrocytic tumors by Western blot analysis. From them the authors selected 23 adult supratentorial ordinary astrocytic tumors and performed quantitative Western blot analysis for each isoform (NCAM 172-180, NCAM 145, NCAM 125-130) to investigate any correlation between the expression of each NCAM isoform and the histologic and biologic malignancy (histology, proliferating cell indices [PCIs] determined by MIBI immunohistochemistry, and manifestation on magnetic resonance images [MRIs]). Immunohistochemistry with antihuman NCAM monoclonal antibody was also performed on the tumors from which cryostat sections were available. RESULTS. Most of the astrocytomas and anaplastic astrocytomas revealed 3 bands at 180, 145, and 125-130kD, whereas in glioblastomas the bands tended to diminish. The expression of each NCAM isoform in astrocytic tumors decreased in proportion to the progression of the histologic malignancy, and the results were also corroborated by immunohistochemical evaluation. An inverse correlation was also observed between the amount of NCAM expression and MIB-1 PCIs. NCAM expression was hardly detectable in those tumors with highly invasive manifestation on MRIs. CONCLUSIONS. To the authors' knowledge, this study provides the first direct evidence that NCAM is down-regulated in the development of the malignancy of astrocytic tumors; and it is suggested that reduced NCAM expression might be involved in the development of biologic malignancy.

KW - Astrocytic tumor

KW - Brain tumor

KW - Glioma

KW - Invasion

KW - Inverse correlation

KW - Malignancy

KW - MIB- 1

KW - Neural cell adhesion molecule

KW - Proliferation

UR - http://www.scopus.com/inward/record.url?scp=0032525219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032525219&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0142(19980515)82:10<1921::AID-CNCR16>3.0.CO;2-V

DO - 10.1002/(SICI)1097-0142(19980515)82:10<1921::AID-CNCR16>3.0.CO;2-V

M3 - Article

C2 - 9587126

AN - SCOPUS:0032525219

VL - 82

SP - 1921

EP - 1931

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 10

ER -